Europe Plasma Fractionation Market
The Europe Plasma Fractionation Market size was valued at US$ 6,824.67 Mn in 2021 and is projected to reach US$ 10,402.95 Mn by 2028, growing at a CAGR of 6.2% during 2021 - 2028.
Report Coverage
- Product: Immunoglobulin, Albumin, Coagulation Factor Concentrates, Protease Inhibitors, Other Plasma Products
- Application: Neurology, Immunology, Hematology, Critical Care, Pulmonology, Other Applications
- End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes
US$ 6,824.67 Mn
Market size in 2021
US$ 10,402.95 Mn
Market Size by 2028
6.2%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Plasma Fractionation Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Plasma Fractionation Market Regional Analysis
6.2 Europe Plasma Fractionation Market Revenue 2019-2028 (US$ Million)
6.3 Europe Plasma Fractionation Market Forecast Analysis
7. Europe Plasma Fractionation Market Analysis – by Product
7.1 Immunoglobulin
- 7.1.1 Overview
- 7.1.2 Immunoglobulin: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Albumin
- 7.2.1 Overview
- 7.2.2 Albumin: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Coagulation Factor Concentrates
- 7.3.1 Overview
- 7.3.2 Coagulation Factor Concentrates: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Protease Inhibitors
- 7.4.1 Overview
- 7.4.2 Protease Inhibitors: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Other Plasma Products
- 7.5.1 Overview
- 7.5.2 Other Plasma Products: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Plasma Fractionation Market Analysis – by Application
8.1 Neurology
- 8.1.1 Overview
- 8.1.2 Neurology: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Immunology
- 8.2.1 Overview
- 8.2.2 Immunology: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Hematology
- 8.3.1 Overview
- 8.3.2 Hematology: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Critical Care
- 8.4.1 Overview
- 8.4.2 Critical Care: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Pulmonology
- 8.5.1 Overview
- 8.5.2 Pulmonology: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.6 Other Applications
- 8.6.1 Overview
- 8.6.2 Other Applications: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Plasma Fractionation Market Analysis – by End User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Clinical Research Laboratories
- 9.2.1 Overview
- 9.2.2 Clinical Research Laboratories: Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Academic Institutes
- 9.3.1 Overview
- 9.3.2 Academic Institutes : Europe Plasma Fractionation Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Plasma Fractionation Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Plasma Fractionation Market Breakdown, by Key Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Plasma Fractionation Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Plasma Fractionation Market Breakdown, by Product
- 10.2.1.1.2 UK: Europe Plasma Fractionation Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Plasma Fractionation Market Breakdown, by End User
- 10.2.1.2 Germany: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Plasma Fractionation Market Breakdown, by Product
- 10.2.1.2.2 Germany: Europe Plasma Fractionation Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Plasma Fractionation Market Breakdown, by End User
- 10.2.1.3 France: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Plasma Fractionation Market Breakdown, by Product
- 10.2.1.3.2 France: Europe Plasma Fractionation Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Plasma Fractionation Market Breakdown, by End User
- 10.2.1.4 Russia: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Plasma Fractionation Market Breakdown, by Product
- 10.2.1.4.2 Russia: Europe Plasma Fractionation Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Plasma Fractionation Market Breakdown, by End User
- 10.2.1.5 Italy: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Plasma Fractionation Market Breakdown, by Product
- 10.2.1.5.2 Italy: Europe Plasma Fractionation Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Plasma Fractionation Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Plasma Fractionation Market Breakdown, by Product
- 10.2.1.6.2 Rest of Europe: Europe Plasma Fractionation Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Plasma Fractionation Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Bharat Serums and Vaccines Limited (BSV)
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bio Products Laboratory Ltd.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Biotest AG.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 CSL Limited
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Grifols, S.A.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Kedrion S.p.A
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Octapharma AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Sanquin
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 SK Plasma
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
